(Reuters) — Abbott Laboratories said Wednesday that fourth-quarter earnings jumped 28 percent on demand for its prescription drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries. The strong performance, based on double-digit sales ...
Copyright CRAIN - Crain's
